Our products feature a patented technology that enables the entirely new biocompatible HA-based gel to be easily injected as a fluid gel at room temperature. This fluid state allows practitioners to deliver the product with precision and ease, utilizing an ultra-thin needle. 

As a result, patients experience a significant decrease in pain and reduced bruising.

Once administered to the targeted area, body temperature activates the fluid’s exceptional ability to form microgel structures, increase viscosity, and prevent migration.

KYLYS technology is set to fundamentally enhance the performance of hyaluronic acid based products.